-
【GE CHENG News】China's first case of drug patent link litigation announced
2025-05-06On April 15, the Beijing Intellectual Property Court publicly sentenced the case of first instance in which the plaintiff Chugai Pharmaceutical Co., Ltd. sued the defendant Wenzhou Haihe Pharmaceutical Co., Ltd. to confirm whether it fell into the scope of patent protection. According to the trial o -
【Global News】Japan likely to consider secret patent non-disclosure system
2025-05-06Japanese Prime Minister, Fumio Kishida, instructed his cabinet to speed up the preparation of legislation promoting economic security at the first meeting of the “Council for the Promotion of Economic Security” in November 2021. The legislation is scheduled to be submitted to the 2022 Ordinary Diet -
【Global News】Pfizer Concludes License Agreement with the Medicines Patent Pool (MPP) for COVID-19 Therapeutic Medicines
2025-05-06Pfizer, a US-based pharmaceutical giant, announced that it has signed a license agreement with the MPP for Paxlovid, an oral antiviral medicine for COVID-19. The MPP is a public health organization in Kenilworth, New Jersey, and is supported by the United Nations and governments including Japan. Pat -
【Global News】Acceleration of proceedings before EPO through PACE: an alternative to PPH
2025-05-06The common way to accelerate proceedings before EPO is through PPH, as EPO has many PPH agreements in force with other patent offices worldwide (see here).An easy alternative to PPH is the PACE program. Under the PACE program, a PACE request may be filed only once during each stage of the procedure, -
【GE CHENG News】How to apply for the cancellation of the registered trademark already been the common name?
2025-05-06In accordance with the provisions of Paragraph 2 of Article 49 of China’s Trademark Law and Article 65 of the Regulations for the Implementation of the Trademark Law, when a registered trademark becomes the common name of its approved products,any unit or individual may file an application to the Tr